Amanote Research
Register
Sign In
P1.03-14 Interaction Between Celecoxib and Cisplatin Is Dependent on the P53 Status in Human NSCLC Cell Lines
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.695
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Jiang
W. Li
L. Ma
L. Zhang
J. Tan
S. Zheng
Y. Liu
Publisher
Elsevier BV
Related search
Disruption of the MDM2–p53 Interaction Strongly Potentiates P53-Dependent Apoptosis in Cisplatin-Resistant Human Testicular Carcinoma Cells via the Fas/FasL Pathway
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
UNC5H4‑induced Apoptosis in Non‑small Cell Lung Cancer Is Not Dependent on P53 Status Only
Oncology Letters
Cancer Research
Oncology
The Interaction Between P53 and Mdm2 Is Independent of MEG3–p53 Association
Cisplatin-Induced Apoptosis in Human Malignant Testicular Germ Cell Lines Depends on MEK/ERK Activation
British Journal of Cancer
Cancer Research
Oncology
Synergistic Interaction Between Cisplatin and Taxol in Human Ovarian Carcinoma Cells in Vitro
British Journal of Cancer
Cancer Research
Oncology
MicroRNA-34a Is Induced via P53 During Cisplatin Nephrotoxicity and Contributes to Cell Survival
Molecular Medicine
Molecular Medicine
Genetics
Molecular Biology
Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines
Journal of Surgical Research
Surgery
P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.03-28 Association Between Molecular Characteristics of CTNNB1 Mutations and Prognosis in Patients With NSCLC in Chinese Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
